Silence Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	479	287	325	672	547	715
Market Cap Growth	79.34%	-11.59%	-51.64%	22.71%	-23.44%	17.04%
Enterprise Value	409	185	152	600	448	612
Last Close Price	1.50	2.00	2.63	1.50	3.25	7.15
PS Ratio	571.42	513.74	7.51	21.23	25.28	42.53
PB Ratio	9.70	4.61	2.42	30.54	20.58	61.93
P/TBV Ratio	12.36	5.59	2.61	57.66	33.06	580.25
P/FCF Ratio	-	-	-	-	-	96.09
P/OCF Ratio	-	-	-	-	-	77.58
EV/Sales Ratio	-	331.26	3.52	18.97	20.67	36.40
EV/FCF Ratio	-	-	-	-	-	82.24
Debt / Equity Ratio	0.00	0.00	0.00	0.02	0.02	0.02
Debt / FCF Ratio	-	-	-	-	-	0.03
Net Debt / Equity Ratio	-1.42	-1.36	-1.10	-3.11	-3.20	-8.61
Net Debt / EBITDA Ratio	0.98	1.04	3.01	1.32	1.68	1.61
Net Debt / FCF Ratio	1.07	1.36	2.17	1.38	1.49	-13.36
Asset Turnover	0.01	0.00	0.27	0.25	0.18	0.14
Quick Ratio	8.82	8.06	10.36	4.15	4.03	5.41
Current Ratio	9.83	8.72	11.14	4.62	4.41	5.69
Return on Equity (ROE)	-92.56%	-90.27%	-58.08%	-223.22%	-273.06%	-448.22%
Return on Assets (ROA)	-29.79%	-30.79%	-19.24%	-26.32%	-26.09%	-31.44%
Return on Capital Employed (ROCE)	-68.40%	-69.80%	-26.70%	-54.00%	-49.70%	-56.50%
Earnings Yield	-15.65%	-30.86%	-13.95%	-8.07%	-9.20%	-7.46%
FCF Yield	-13.69%	-21.70%	-20.89%	-7.37%	-10.45%	1.04%
Buyback Yield / Dilution	-0.35%	-2.12%	-24.69%	-15.21%	-8.58%	-8.78%